Viewing nowOlmesartan Medoxomil Tablet 20mg
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

MFDS item code 201100913 · Approved 2011.02.24 · Insurance code 646003510
Treatment of essential hypertension
Essential hypertension is a condition in which blood pressure is abnormally high, and this medication helps lower blood pressure to reduce the risk of cardiovascular diseases. With consistent use, blood pressure can be controlled, and it is also effective in preventing complications. Therefore, it is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. <Elderly patients> No dosage adjustment is necessary when this medicine is administered to elderly patients aged 65 years or older. Although no overall differences in the efficacy or safety of this medicine have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and it may be increased to a maximum of 20mg daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use in these patients.
Safety and efficacy in pediatric patients have not been established.
This medication may cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It is prohibited for use in individuals allergic to any ingredients in this medication, pregnant women, nursing mothers, patients undergoing kidney dialysis, patients with severe liver impairment, patients with biliary obstruction, and certain genetically lactose intolerant patients. Patients with reduced blood volume or sodium may experience hypotension, so their condition should be carefully evaluated before administration, and blood pressure changes should be closely monitored during treatment. Patients with kidney dysfunction or those who have received a kidney transplant may experience changes in kidney function while taking this medication, so regular blood tests are necessary. There is a risk of elevated serum potassium levels while taking this medication, so patients with heart failure or kidney disease should regularly check their potassium levels. Patients with heart-related conditions such as aortic stenosis, mitral valve stenosis, or obstructive cardiomyopathy should take caution while using this medication. This medication may cause side effects such as dizziness, so caution is advised during dangerous tasks such as operating machinery or driving. Common side effects that may occur include dizziness, headache, back pain, indigestion, palpitations, rash, etc., most of which are temporary and mild symptoms. Rarely, serious adverse reactions such as angioedema, liver dysfunction, hyperkalemia, and acute renal failure may occur, so immediate consultation with medical personnel is needed if symptoms arise. If chronic diarrhea or weight loss persists, it may be indicative of a chronic malabsorption-like gastrointestinal disorder related to this medication, so use should be discontinued and a physician consulted. Co-administration with other antihypertensive agents, potassium-sparing diuretics, or potassium supplements may lead to dangerously elevated potassium levels, so caution is needed with combination therapy. Concomitant use with lithium may increase lithium concentration, leading to toxicity, so co-administration should be avoided. Co-administration with non-steroidal anti-inflammatory drugs may increase the risk of renal function impairment, so hydration and monitoring of kidney function are necessary. Ideally, this medication should be avoided during pregnancy, particularly in the second and third trimesters, and if unavoidable, the condition of the fetus should be regularly monitored through ultrasound or other means. If breastfeeding, it is recommended to either discontinue breastfeeding or the medication, as it may be passed into breast milk. Safety and efficacy in pediatric patients have not been adequately established, so it is better not to use it in children. Elderly patients may experience slower drug metabolism, so dose adjustment and careful observation are required when administering this medication. In cases of overdose, hypotension and palpitations may occur, and appropriate emergency treatment is necessary if symptoms are severe. This medication does not provide evidence of carcinogenicity or genotoxicity even with long-term use; however, rare experimental results related to cell mutations have been reported, so caution is necessary.
Dizziness, back pain, bronchitis, increased creatine phosphokinase, diarrhea, headache, hematuria, hyperglycemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, sinusitis, cough, chest pain, peripheral edema, vertigo, abdominal pain, indigestion, gastritis, nausea, palpitations, hypercholesterolemia, hyperlipidemia, hyperuricemia, arthralgia, arthritis, myalgia, rash, facial edema, asthenia, angioedema, anaphylactic reaction, vomiting, chronic malabsorption syndrome - similar to intestinal disease, intestinal vascular edema, rhabdomyolysis, hyperkalemia, acute renal failure, elevated serum creatinine, hair loss, pruritus, urticaria, autoimmune hepatitis, headache, hypertension, epistaxis, asthma, positional dizziness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid contact with air or moisture, and it is advisable to keep it at room temperature between 1 degree and 25 degrees Celsius. Proper storage helps maintain the medication's effectiveness for a long time.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 20mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.